Iqvia Holdings (IQV) Cash & Current Investments (2011 - 2026)
Iqvia Holdings (IQV) posted Cash & Current Investments of $2.1 billion for Q2 2026, down 1.09% sequentially from $2.1 billion in Q1 2026, and down 4.94% YoY from $2.2 billion in Q2 2025.
Iqvia Holdings (IQV) Cash & Current Investments (2011 - 2026) Analysis & Trends
Iqvia Holdings has reported Cash & Current Investments for 16 years, with the latest figure at $2.1 billion in Q2 2026.
- Quarterly Cash & Current Investments fell 4.94% year-over-year to $2.1 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $2.1 billion (down 4.94% YoY) and the FY2025 annual result came in at $2.1 billion, up 16.17% from the prior year.
- Cash & Current Investments retreated to $2.1 billion in Q2 2026 per IQV's latest filing, from $2.1 billion in the prior quarter.
- Over five years, Cash & Current Investments peaked at $2.2 billion in Q2 2025 and troughed at $1.3 billion in Q4 2022.
- A 5-year average of $1.7 billion and a median of $1.6 billion in 2023 frame the typical range for Cash & Current Investments.
- The sharpest annual moves came in 2022 and 2025: Cash & Current Investments sank 37.84% in 2022, then jumped 30.39% in 2025.
- Over 5 years, Cash & Current Investments stood at $1.3 billion in 2022, then increased by 14.29% to $1.5 billion in 2023, then climbed by 23.2% to $1.8 billion in 2024, then increased by 16.17% to $2.1 billion in 2025, then decreased by 2.85% to $2.1 billion in 2026.
- According to Business Quant data, Cash & Current Investments over the past three periods registered $2.1 billion, $2.1 billion, and $2.1 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 4.06 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 4.35 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 196.93 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 1.81 Bn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 2.08 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 1.10 Bn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 1.17 Bn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 51.40 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 626.00 Mn |
| 10 | Labcorp Holdings | 25.87 Bn | 24.89 Bn | 1.01 Bn | 981.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.08 Bn |
| Mar 31, 2026 | 2.10 Bn |
| Dec 31, 2025 | 2.14 Bn |
| Sep 30, 2025 | 1.97 Bn |
| Jun 30, 2025 | 2.19 Bn |
| Mar 31, 2025 | 1.88 Bn |
| Dec 31, 2024 | 1.84 Bn |
| Sep 30, 2024 | 1.71 Bn |
| Jun 30, 2024 | 1.68 Bn |
| Mar 31, 2024 | 1.58 Bn |
| Dec 31, 2023 | 1.50 Bn |
| Sep 30, 2023 | 1.33 Bn |
| Jun 30, 2023 | 1.49 Bn |
| Mar 31, 2023 | 1.60 Bn |
| Dec 31, 2022 | 1.31 Bn |
| Sep 30, 2022 | 1.36 Bn |
| Jun 30, 2022 | 1.52 Bn |
| Mar 31, 2022 | 1.49 Bn |
| Dec 31, 2021 | 1.48 Bn |
| Sep 30, 2021 | 1.57 Bn |